APA (7th ed.) Citation

Buonomo, A. R., Maraolo, A. E., Scotto, R., Foggia, M., Zappulo, E., Congera, P., . . . Gentile, I. (2020). Efficacy and safety of ceftolozane/tazobactam as therapeutic option for complicated skin and soft tissue infections by MDR/XDR Pseudomonas aeruginosa in patients with impaired renal function: A case series from a single-center experience. Infection, 48(2), 303. https://doi.org/10.1007/s15010-020-01390-y

Chicago Style (17th ed.) Citation

Buonomo, A. R., A. E. Maraolo, R. Scotto, M. Foggia, E. Zappulo, P. Congera, S. Parente, and I. Gentile. "Efficacy and Safety of Ceftolozane/tazobactam as Therapeutic Option for Complicated Skin and Soft Tissue Infections by MDR/XDR Pseudomonas Aeruginosa in Patients with Impaired Renal Function: A Case Series from a Single-center Experience." Infection 48, no. 2 (2020): 303. https://doi.org/10.1007/s15010-020-01390-y.

MLA (9th ed.) Citation

Buonomo, A. R., et al. "Efficacy and Safety of Ceftolozane/tazobactam as Therapeutic Option for Complicated Skin and Soft Tissue Infections by MDR/XDR Pseudomonas Aeruginosa in Patients with Impaired Renal Function: A Case Series from a Single-center Experience." Infection, vol. 48, no. 2, 2020, p. 303, https://doi.org/10.1007/s15010-020-01390-y.